Urinary excretion of DOPA and metabolites by patients with melanoma
- 1 July 1970
- Vol. 26 (1) , 146-149
- https://doi.org/10.1002/1097-0142(197007)26:1<146::aid-cncr2820260119>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Multiple Forms of Tyrosinase from Human Melanoma**From the Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts 02114.Journal of Investigative Dermatology, 1969
- One-Dimensional Paper Chromatographic Method for Determination of Urinary Homovanillic AcidClinical Chemistry, 1968
- Vanillactic acid in the urine of melanoma patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1967
- Precursors of melanin in the urine in malignant melanomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1967
- Identification of two new metabolites in melanoma urine: 5-hydroxy-6-methoxyindole-2-carboxylic and 5-methoxy-6-hydroxyindole-2-carboxylic acidsClinica Chimica Acta; International Journal of Clinical Chemistry, 1967
- Tyrosinase Inhibitor in Fortner's Amelanotic and Melanotic Malignant Melanoma*Journal of Investigative Dermatology, 1967
- Incidence and Significance of MelanogenuriaBMJ, 1966
- 3,4-DIHYDROXYPHENYLALANINE (DOPA) EXCRETION IN PATIENTS WITH MALIGNANT MELANOMAThe Lancet, 1962
- Homovanillic acid and its relation to tyrosine metabolism in melanomaClinica Chimica Acta; International Journal of Clinical Chemistry, 1962
- A Fluorimetric Method for the Determination of Dopamine (3‐Hydroxytyramine.)Acta Physiologica Scandinavica, 1958